XML 54 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Supplementary Quarterly Financial Information (unaudited)
 12 Months Ended
Dec. 31, 2015
Supplementary Quarterly Financial Information (unaudited) [Abstract]  
Supplementary Quarterly Financial Information (unaudited)
Supplementary Quarterly Financial Information (unaudited)
Quarterly earnings per share amounts may not sum to the totals for each of the years, since quarterly computations are based on weighted average common shares outstanding during each quarter.
In thousands, except per share data)
 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Year
2015
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
10,849

 
$
13,590

 
$
11,309

 
$
15,420

 
$
51,168

Gross profit
 
5,281

 
6,689

 
4,537

 
8,191

 
24,698

Loss from operations
 
(4,572
)
 
(2,265
)
 
(4,877
)
 
(4,957
)
 
(16,671
)
Net loss
 
(4,862
)
 
(2,152
)
 
(4,416
)
 
(4,910
)
 
(16,340
)
Net loss per share (Basic and Diluted)
 
(0.27
)
 
(0.16
)
 
(0.26
)
 
(0.28
)
 
(0.97
)
2014
 
 
 
 
 
 
 
 
 
 
Revenues(a)
 
$
—

 
$
4,432

 
$
9,658

 
$
14,706

 
$
28,796

Gross profit (loss)
 
—

 
(577
)
 
4,126

 
7,954

 
11,503

Loss from operations
 
(4,645
)
 
(8,522
)
 
(8,022
)
 
(2,345
)
 
(23,534
)
Net loss(b)
 
(5,995
)
 
(4,638
)
 
(6,917
)
 
(2,370
)
 
(19,920
)
Net loss per share (Basic and Diluted)
 
(1.26
)
 
(0.94
)
 
(0.82
)
 
(0.17
)
 
(2.23
)
 
 
 
 
 
 
 
 
 
 
 
(a) Revenue from commercial operations began in June 2014 following the acquisition of the CTRM business. Prior to June 2014, Vericel was a development stage entity.
 
 
 
 
 
 
 
 
 
 
 
(b) The net loss in the second quarter of 2014 includes a $3.5 million bargain purchase gain as a result of the CTRM business acquisition.